Bespak and Orbia Advance Corporation announced a collaboration intended to accelerate the transition to climate-friendly inhalers utilising Orbia Fluor & Energy Materials’ low global warming potential propellant known as Zephex 152a.
SGS technicians at the Wavre laboratory have paired the Malvern Spraytec system with the Mighty Runt actuator to precisely assess how factors like device actuation – including pump velocity and force – and droplet size impact drug delivery.
Biosynth announced that its board of directors has appointed Matt Gunnison as the company's new chief executive officer and a member of the board of directors, effective immediately.
ARC Innovation announced the successful $5.1 million funding round of Starget Pharma, a startup specialising in precise cancer diagnosis and targeted radiotherapy.
iotaSciences announced the upcoming launch of its newly developed Single-Cell Cloning Platform XT at the Cell 2024 event in London (UK) from November 6-8, 2024.
UK-based drug discovery organisation Concept Life Sciences (CLS), backed by mid-market private equity investment firm Limerston Capital, has completed the acquisition of Charnwood Discovery.
The company's pci | bridgeTM enhances supply chain visibility and reduces time spent on manual activities such as forecasting, inventory management, reporting, supplier management and document sharing.
VALANX Biotech and FinaBio sign joint licensing agreement to commercialise ready-to-conjugate vaccine carrier protein CRM197 will enable rapid development of conjugate vaccines.
Berry Global has launched a new easy-squeeze ophthalmic 10ml bottle that has been qualified for use with Aptar Pharma’s globally recognised Ophthalmic Squeeze Dispenser (OSD).
